HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3 - PubMed (original) (raw)
Affiliations
- PMID: 3422031
Free article
HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3
W T Dalton Jr et al. Blood. 1988 Jan.
Free article
Abstract
The leukemia from which the human cell line HL-60 was derived was classified in 1976 as acute progranulocytic leukemia (APL), although it was recognized to show a number of atypical features. In the ensuing 10 years, the concept of APL and its integral association with t(15;17) has evolved, and the concept of APL as a morphologically recognizable entity has become embodied in the term French-American-British classification M3 (FAB-M3). It is now recognized that not every case of leukemia with a high proportion of progranulocytes can be classified as FAB-M3. We reviewed the light and ultrastructural morphology of the original diagnostic material from this case, and we report that the leukemia from which HL-60 was derived does not conform to the currently recognized entity of FAB-M3 and is more appropriately classified as an acute myeloblastic leukemia with maturation, FAB-M2.
Similar articles
- Immunophenotyping of acute myeloid leukemia by immuno-alkaline phosphatase (APAAP) labeling with a panel of antibodies.
Davey FR, Erber WN, Gatter KC, Mason DY. Davey FR, et al. Am J Hematol. 1987 Oct;26(2):157-66. doi: 10.1002/ajh.2830260206. Am J Hematol. 1987. PMID: 2821801 - Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant.
Piedras J, López-Karpovitch X, Cárdenas R. Piedras J, et al. Cytometry. 1998 Aug 1;32(4):286-90. Cytometry. 1998. PMID: 9701397 - Morphology and classification of acute myeloid leukemias.
Krause JR. Krause JR. Clin Lab Med. 2000 Mar;20(1):1-16. Clin Lab Med. 2000. PMID: 10702892 Review. - The classification of acute leukaemia (AL) and its clinical significance.
Catovsky D, Tavares de Castro J. Catovsky D, et al. Schweiz Med Wochenschr. 1983 Oct 8;113(40):1434-7. Schweiz Med Wochenschr. 1983. PMID: 6359396 Review.
Cited by
- Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.
Wildenhain S, Ingenhag D, Ruckert C, Degistirici Ö, Dugas M, Meisel R, Hauer J, Borkhardt A. Wildenhain S, et al. J Biol Chem. 2012 Nov 23;287(48):40703-12. doi: 10.1074/jbc.M111.308965. Epub 2012 Oct 8. J Biol Chem. 2012. PMID: 23048027 Free PMC article. - Spicamycin and KRN5500 induce apoptosis in myeloid and lymphoid cell lines with down-regulation of bcl-2 expression and modulation of promyelocytic leukemia protein.
Zhang WJ, Ohnishi K, Yoshida H, Pan L, Maksumova L, Muratkhodjaev F, Luo JM, Shigeno K, Fujisawa S, Naito K, Nakamura S, Shinjo K, Takeshita A, Ohno R. Zhang WJ, et al. Jpn J Cancer Res. 2000 Jun;91(6):604-11. doi: 10.1111/j.1349-7006.2000.tb00988.x. Jpn J Cancer Res. 2000. PMID: 10874212 Free PMC article. - Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells.
Song H, Fares M, Maguire KR, Sidén A, Potácová Z. Song H, et al. PLoS One. 2014 Dec 15;9(12):e114457. doi: 10.1371/journal.pone.0114457. eCollection 2014. PLoS One. 2014. PMID: 25502932 Free PMC article. - Identification of triciribine as a novel myeloid cell differentiation inducer.
Suzuki S, Suzuki S, Sato-Nagaoka Y, Ito C, Takahashi S. Suzuki S, et al. PLoS One. 2024 May 14;19(5):e0303428. doi: 10.1371/journal.pone.0303428. eCollection 2024. PLoS One. 2024. PMID: 38743735 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials